Melis Kant works as a Biochemist in the Biomaterials Group. Her work is focused on cellular quality assessment by developing robust assays that identify metabolic signatures associated with cell viability, death, and functional integrity. She specializes in mass spectrometric quantification of small molecules, peptides, and DNA damage lesions, with a strong focus on method development, optimization, and validation to support high-impact biomedical research.
Research Interests:
MML Measurement Science Excellence Accolade for The Outstanding Measurements at National Institute of Standards and Technology September 2022
"The inhibition of a major human DNA repair enzyme by potential anticancer drugs, the products in DNA irradiated by Ne-22 ion beams in relation to cancer therapy and DNA lesions in cooked food associated with cancer."
Federation of European Biochemical Societies Poster Award September 2018
"Evaluation of Theoretical and Practical Course on DNA Damage, Repair and Its Measurement by Tandem Mass Spectrometry" in FEBS Workshop on Molecular Life Sciences: Training Tomorrow’s Scientists
Turkish Society of Biochemistry - Prof. Dr. Nazmi Ozer Science Award October 2017
"Elevated Urinary Levels of 8-Oxo-2’-deoxyguanosine, (5’R)- and (5’S)- 8,5’-Cyclo-2’-deoxyadenosines, and 8-Iso-prostaglandin F2a as Potential Biomarkers of Oxidative Stress in Patients with Prediabetes"
IX. Dr. Aysun – Ahmet Kucukel Medical Best Project Award March 2017
"Bacterial Heat Shock Protein GroEL (Hsp64) Exerts Immunoregulatory Effects on T Cells by Utilizing Apoptosis"
Turkish Psychiatric Association Research Incentive Award May 2016
"Relationship of DNA Damage and Repair with Psychiatric Symptoms and Survival in Depression" in 20. Years Meeting and Clinical Education Symposium